A buyout hasn't really been discussed here on the board but I definitely think its a possibility down the road. We're probably looking at around a year or two before that would occur IMO
Pfizer could potentially be interested later on down the road maybe to figure out a way to extend their patent by using Rapimed technology. We discussed the possibilities on the board but it might be a little ways off.
I was thinking if SCRC created an ED pill using rapid release technology, wouldn't Pfizer be the first in line to work out a deal with Scrips to benefit everyone? I'm just throwing the old ball around in my head, throwing out some ideas.
Market Data 
Markets 
AI
